Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
NASDAQ:VVOS
Price:
2.45 USD
6.52%
Market Closed
Updated:
Jun 10, 2024
Vivos Therapeutics Inc
Total Liabilities & Equity
|
Vivos Therapeutics Inc
Total Liabilities & Equity Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Total Liabilities & Equity
$10.7m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Total Liabilities & Equity
$17.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Liabilities & Equity
$14B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
CVS Health Corp
NYSE:CVS
|
Total Liabilities & Equity
$249.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
13%
|
|
|
Cigna Corp
NYSE:CI
|
Total Liabilities & Equity
$153.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
11%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Liabilities & Equity
$16.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
9%
|
See Also
What is Vivos Therapeutics Inc's Total Liabilities & Equity?
Total Liabilities & Equity
10.7m
USD
10.7m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Total Liabilities & Equity amounts to 10.7m USD.
What is Vivos Therapeutics Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
6%
6%
Over the last year, the Total Liabilities & Equity growth was -22%. The average annual Total Liabilities & Equity growth rates for Vivos Therapeutics Inc have been -25% over the past three years , 6% over the past five years .
You don't have any saved screeners yet
